Atalaya Mining PLC Announces Q2 and H1 2021 Interim Financial Statements
Unaudited Interim Condensed Consolidated Financial Statements for the period ended 30 June 2021 NICOSIA, CYPRUS…
Unaudited Interim Condensed Consolidated Financial Statements for the period ended 30 June 2021 NICOSIA, CYPRUS…
BISHOPSGATE, LONDON / ACCESSWIRE / August 11, 2021 / The Board of Directors of SolGold…
STRONG OVERALL PERFORMANCE IN THE FIRST HALF OF 2021 GAINING SPEED RAPID CAPACITY BUILD-UP TO…
J.POD (R) 1 US PROVIDES UNIQUELY FLEXIBLE CGMP MANUFACTURING OF KILOGRAMS TO METRIC TONS OF…
SINGAPORE / ACCESSWIRE / August 11, 2021 / Global Schools Foundation (GSF), together with its…
WINNIPEG, MB / ACCESSWIRE / August 10, 2021 / Bird River Resources Inc. (“Bird River”…
BUENOS AIRES, ARGENTINA / ACCESSWIRE / August 10, 2021 / Cablevisión Holding S.A., (“Cablevision Holding”,…
HONOLULU, HI / ACCESSWIRE / August 10, 2021 / Pono Capital Corp (the “Company”) announced…
Acquisition Adds Cloud-Based Print Management Capabilities and Enhances Kofax’s Intelligent Automation Platform Irvine, CA –…
New relationship is set to increase Westcon-Comstor’s value to channel partners by bolstering its Zero…
Netacea research reveals the high cost of unwanted bot traffic Manchester, UK – 11th August…
London based public law and human rights practice, Rook Irwin Sweeney, has proved the value…
FLOWER MOUND, Texas., Aug. 11, 2021 /PRNewswire/ — Athletico Physical Therapy has opened a new…
MARSEILLE, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II…
Marseille, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II…
NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical…
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today Heather…
RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) —…
ALLN-346 well-tolerated in recently completed Phase 1b study; first patients dosed in Phase 2a program…